Todd Hudnall and Skip Devanny will represent RxStrategies at Cardinal Health’s RBC 2019 in Nashville, July 17-20. Learn more about RBC by visiting their site. Contact us to connect during the conference, and stop by booth 118 to learn about how our comprehensive solutions help keep your 340B program on the right track.
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Vyxeos™ (cytarabine and daunorubicin) – August 3, 2017 – The U.S. Food and Drug Administration approved Vyxeos™ for the treatment of adults with two types of acute… Read more »